Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: J Heart Lung Transplant. 2013 Aug;32(8):784–791. doi: 10.1016/j.healun.2013.05.015

Table 2.

IVUS findings

Sirolimus (N=61) CNI (N=85) P
IVUS follow-up period, yrs 2.9 (2.0, 3.6) 2.3 (1.7, 3.2) 0.11
Vessel volume index
    Baseline, mm3/mm 16.7±4.7 16.8±4.8 0.91
    Follow-up, mm3/mm 16.7±5.1 17.2±4.3 0.58
    Change from baseline, mm3/mm 0.0±3.6 0.3±3.0 0.10
Lumen volume index
    Baseline, mm3/mm 12.2±4.1 12.1±4.2 0.91
    Follow-up, mm3/mm 11.2±4.1 11.2±3.6 0.95
    Change from baseline, mm3/mm −0.9±3.6* −0.9±3.2* 0.98
Plaque volume index
    Baseline, mm3/mm 4.6±2.4 4.8±2.5 0.76
    Follow-up, mm3/mm 5.4±2.8 6.0±3.0 0.25
    Change from baseline, mm3/mm 0.8±1.5 1.2±1.6 0.004
Plaque components
Fibrous
    Baseline, mm3/mm 0.5 (0.0, 1.4) 0.6 (0.0, 1.8) 0.37
    Follow-up, mm3/mm 0.9 (0.2, 2.2) 1.1 (0.2, 2.4) 0.50
    Change from baseline, mm3/mm 0.4±1.0 0.4±1.2 0.42
Fibrofatty
    Baseline, mm3/mm 0.1 (0.0, 0.2) 0.1 (0.0, 0.3) 0.30
    Follow-up, mm3/mm 0.1 (0.0, 0.2) 0.1 (0.0, 0.3) 0.16
    Change from baseline, mm3/mm 0.0±0.3 0.0±0.6 0.96
Necrotic core
    Baseline, mm3/mm 0.1 (0.0, 0.4) 0.1 (0.0, 0.4) 0.63
    Follow-up, mm3/mm 0.3 (0.0, 1.1) 0.3 (0.0, 0.9) 0.96
    Change from baseline, mm3/mm 0.3±0.6 0.3±0.6 0.92
Dense calcium
    Baseline, mm3/mm 0.0 (0.0, 0.1) 0.0 (0.0, 0.2) 0.12
    Follow-up, mm3/mm 0.0 (0.0, 0.3) 0.0 (0.0, 0.4) 0.89
    Change from baseline, mm3/mm 0.2±0.4 0.1±0.3 0.25

Data are expressed as mean±SD, or median (interquartile range).

*

P<0.05

P<0.01

P<0.001 vs. baseline.

CNI indicates calcineurin inhibitors; and IVUS, intravascular ultrasound.